≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Other encephalitis

DOID EFO Endpoint Browser PheWeb

G6_ENCEPHOTH

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

1075

4. Check minimum number of events

None

1075

5. Include endpoints

None

1075

6. Filter based on genotype QC (FinnGen only)

1033

Control definitions (FinnGen only)

Control exclude
G6_NEUINFL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8321 4179 4069
Only index persons 7092 3622 3470
Unadjusted period prevalence (%)
Whole population 0.12 0.12 0.11
Only index persons 0.13 0.13 0.13
Median age at first event (years)
Whole population 44.69 46.74 42.37
Only index persons 42.17 44.29 39.97

-FinnGen-

Key figures

All Female Male
Number of individuals 1033 571 462
Unadjusted period prevalence (%) 0.21 0.20 0.21
Median age at first event (years) 50.30 46.74 54.69

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1075
Matched controls
10750
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
TAB00
NOMESCO Finland
Lumbar puncture
18.4
307.7
289
211
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
+∞
307.7
509
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
9.1
206.7
300
438
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
14.2
159.9
154
125
N03AX14
ATC
levetiracetam; systemic
13.9
137.6
133
108
XA800
NOMESCO Finland
Neuropsychological investigation
10.1
136.2
167
193
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
134.2
126
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
8.3
121.1
175
247
A86
ICD-10 Finland
Unspecified viral encephalitis
226.9
119.3
121
6
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
+∞
115.8
109
*
AA1AD
NOMESCO Finland
CT of head and brain
4.1
111.2
468
1689
32309
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Unspecified
+∞
110.3
104
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.9
109.7
134
153
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
12.3
95.3
98
87
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
12.5
85.2
86
74
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
16.3
76.6
66
43
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.8
75.8
293
963
G35
ICD-10 Finland
Multiple sclerosis
13.3
71.5
69
55
N03AX18
ATC
lacosamide; systemic
24.9
70.3
50
21
A87.9
ICD-10 Finland
Viral meningitis, unspecified
23.8
69.1
50
22
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.4
67.1
196
524
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.8
67.0
132
253
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
13.1
64.6
63
51
N03AF02
ATC
oxcarbazepine; oral
7.3
63.2
97
144
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.5
55.1
67
75
R4120
NOMESCO Finland
Occupational therapy
4.5
54.0
143
352
ZX120
NOMESCO Finland
Intravenous
4.0
53.7
174
498
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
53.5
258
956
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
20.3
53.1
41
21
5AB01, ,
NOMESCO Finland
144.8
52.3
55
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
16.2
52.3
45
29
G05.1*J09
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in influenza caused by certain identified influenza viruses
+∞
51.5
49
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
16.1
48.8
42
27
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
16.1
48.8
42
27
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
+∞
48.3
46
*
R41.0
ICD-10 Finland
Disorientation, unspecified
7.3
45.3
68
98
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
+∞
45.1
43
*
G05.1*B01.1
ICD-10 Finland
Varicella encephalitis
+∞
44.1
42
*
F05.9
ICD-10 Finland
Delirium, unspecified
8.8
40.6
52
62
N05BA09
ATC
clobazam; oral
16.7
40.2
34
21
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
38.3
294
1371
B00.4
ICD-10 Finland
Herpesviral encephalitis
390.7
38.3
38
*
N03AG01
ATC
valproic acid; systemic, rectal
4.0
38.1
118
324
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.5
37.5
142
447
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
36.9
542
3343
G05.1*B02.0
ICD-10 Finland
Zoster encephalitis
+∞
36.7
35
*
G03.9
ICD-10 Finland
Meningitis, unspecified
369.2
36.2
36
*
L04AA06
ATC
mycophenolic acid; systemic
7.5
35.9
52
72
A28
ICPC
Limited function/disability NOS
2.7
35.5
221
925
Z2445
NOMESCO Finland
Psychologist
4.5
34.5
89
213
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
34.3
218
921
183
Kela drug reimbursment
Lamotrigin and topiramate
10.9
34.1
37
35
109
Kela drug reimbursment
Multiple sclerosis
10.3
33.8
38
38
N99
ICPC
Neurological disease other
9.8
33.4
39
41
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
7.5
32.8
48
67
R50.9
ICD-10 Finland
Fever, unspecified
2.6
31.6
221
976
3238B
ICD-9 Finland
Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS,ENCEPHALOMYELITIS) VIROSA]
+∞
31.4
30
*
WX892
NOMESCO Finland
Monitored bed care
3.4
30.5
120
386
R4110
NOMESCO Finland
Physiotherapy
2.2
29.8
343
1882
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
29.7
214
957
N03AX12
ATC
[U] gabapentin; oral
2.5
29.6
219
991
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
29.4
102
302
R20.2
ICD-10 Finland
Paraesthesia of skin
3.3
28.9
116
377
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
106.3
28.8
31
*
N03AB02
ATC
phenytoin; systemic
8.3
28.8
38
47
H02AB09
ATC
hydrocortisone; systemic
5.8
28.3
53
96
R4130
NOMESCO Finland
Speech therapy
5.5
28.0
55
104
L28
ICPC
Limited function/disability (L)
2.5
27.6
215
994
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
27.3
139
519
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.0
27.3
49
85
2AB04, ,
NOMESCO Finland
99.3
26.8
29
*
N03AX16
ATC
[U] pregabalin
2.2
26.6
283
1493
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
9.6
26.3
31
33
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
+∞
25.1
24
*
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
9.3
24.8
30
33
TKC20
NOMESCO Finland
Catheterisation of bladder
3.2
24.5
102
339
M05BA04
ATC
alendronic acid; oral
3.1
24.2
110
385
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
24.2
174
773
6BA02, ,
NOMESCO Finland
47.8
23.4
28
6
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
9.0
23.4
29
33
R33
ICD-10 Finland
Retention of urine
3.1
23.3
106
371
L04AX01
ATC
azathioprine; systemic
3.7
23.3
75
211
R51.80
ICD-10 Finland
Headache
2.3
23.1
213
1054
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.9
23.1
52
111
G05.1*J10.8
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in influenza caused by other identified influenza virus
+∞
23.0
22
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
22.9
148
623
N28
ICPC
Limited function/disability (N)
6.8
22.2
35
53
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
9.2
22.1
27
30
Z3226
NOMESCO Finland
Physiotherapist
2.2
22.1
227
1173
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
22.0
167
758
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.1
22.0
47
96
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.7
22.0
28
33
N71
ICPC
Meningitis/encephalitis
+∞
21.9
21
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.4
21.7
83
261
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
21.6
290
1656
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.6
21.5
131
536
H02AB06
ATC
prednisolone; systemic
1.9
21.4
520
3608
M03BX01
ATC
baclofen; systemic
5.8
21.3
39
69
R42
ICD-10 Finland
Dizziness and giddiness
2.1
21.0
256
1409
H02AB07
ATC
prednisone; oral
2.3
20.7
172
811
Z3231
NOMESCO Finland
Registered nurse
2.0
20.5
319
1912
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
49.0
20.2
24
5
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.7
19.7
117
472
WW400
NOMESCO Finland
Plasmaferesis
203.6
19.6
20
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
20.5
19.1
28
14
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
19.1
98
366
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
18.9
87
306
XA400
NOMESCO Finland
EEG
17.5
18.8
29
17
N03AF01
ATC
carbamazepine; oral, rectal
3.2
18.7
76
248
Z2221
NOMESCO Finland
Medical doctor
1.9
18.4
316
1945
WX730
NOMESCO Finland
Conventional respirator
6.7
18.4
29
44
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
7.3
18.3
27
38
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
17.9
343
2184
32308
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Alia definita
+∞
17.8
17
*
G05.1*A85.0
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis (in) enteroviral
+∞
17.8
17
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
24.5
17.4
24
10
ZXD05
NOMESCO Finland
Urgent procedure
1.8
17.2
343
2206
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.0
17.0
26
38
N03AX09
ATC
lamotrigine; oral
3.1
17.0
72
241
J05AB11
ATC
valaciclovir; oral
2.1
16.8
170
867
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
16.7
16
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.8
16.6
85
317
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
172.6
16.5
17
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.3
16.3
33
64
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.6
16.3
31
57
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
6.3
16.0
27
44
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
+∞
15.7
15
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.7
15.4
85
330
J01MA12
ATC
levofloxacin; systemic
2.0
15.3
201
1124
RS221, ,
NOMESCO Finland
5.6
15.3
29
53
JN4BD
NOMESCO Finland
Extensive body CT
2.3
15.1
119
546
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
15.1
376
2558
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
14.2
15.1
25
18
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.5
15.0
29
54
N05BA01
ATC
diazepam; systemic, rectal
2.1
14.9
155
796
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
6.9
14.9
23
34
N03AE01
ATC
clonazepam; systemic
2.9
14.9
73
266
G04.0
ICD-10 Finland
Acute disseminated encephalitis
+∞
14.6
14
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.5
14.5
93
389
ZXD35
NOMESCO Finland
Usual procedure
3.5
14.4
49
143
G40.89
ICD-10 Finland
Other epilepsy
17.3
14.3
22
13
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.8
14.3
73
272
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.7
14.2
45
125
J01AA02
ATC
doxycycline; systemic
1.7
14.2
790
6596
R11
ICD-10 Finland
Nausea and vomiting
2.3
14.0
109
498
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.1
13.9
29
58
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
54.1
13.8
16
*
A02BC02
ATC
pantoprazole; systemic
1.7
13.8
686
5534
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.6
13.7
46
133
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.6
13.6
80
320
C03CA01
ATC
furosemide; systemic
1.7
13.6
285
1838
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
141.7
13.5
14
*
J01DB01
ATC
cefalexin; oral
1.8
13.3
872
7539
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
40.6
13.2
16
*
Z2446
NOMESCO Finland
Social worker
2.4
13.1
91
395
J96.0
ICD-10 Finland
Acute respiratory failure
5.7
12.9
24
43
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
12.9
214
1286
A06AD11
ATC
lactulose; oral
2.0
12.9
152
816
N05AH04
ATC
quetiapine; oral
1.8
12.7
205
1221
P01BA02
ATC
hydroxychloroquine; oral
2.4
12.6
93
415
N05CF01
ATC
zopiclone; oral
1.7
12.5
326
2222
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
12.5
193
1133
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
+∞
12.5
12
*
ZXY02
NOMESCO Finland
Neuropsychologist
10.2
12.5
24
24
R47.0
ICD-10 Finland
Dysphasia and aphasia
10.2
12.5
24
24
N03AX11
ATC
topiramate; oral
3.6
12.5
41
117
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.2
12.3
49
158
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.4
12.3
24
45
N29
ICPC
Neurological sympt/complt other
4.6
12.2
29
65
H53.2
ICD-10 Finland
Diplopia
3.3
12.2
47
149
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.7
12.1
66
255
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
21.6
12.0
17
8
N06AX11
ATC
mirtazapine; oral
1.6
12.0
351
2461
R53
ICD-10 Finland
Malaise and fatigue
1.7
12.0
259
1678
G41.0
ICD-10 Finland
Grand mal status epilepticus
47.2
11.9
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
11.7
264
1729
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
30.4
11.7
15
5
G81.9
ICD-10 Finland
Hemiplegia, unspecified
5.8
11.5
21
37
G73.7*M32.1
ICD-10 Finland
Myopathy in systemic lupus erythematosus
+∞
11.5
11
*
F07.1
ICD-10 Finland
Postencephalitic syndrome
+∞
11.5
11
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.5
11.5
39
114
N02BF01
ATC
gabapentin; oral
2.3
11.5
88
399
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.8
11.2
34
92
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.2
11.2
98
470
R1260
NOMESCO Finland
Evaluation of communicative skills
4.3
11.1
28
66
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
11.0
119
619
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.5
10.9
68
281
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
10.7
10.8
20
19
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
10.7
107
540
F05.8
ICD-10 Finland
Other delirium
13.1
10.7
18
14
B02.0
ICD-10 Finland
Zoster encephalitis
60.6
10.6
12
*
SPAT1254
SPAT
Administration of medicine
1.8
10.6
162
945
J01MA02
ATC
ciprofloxacin; systemic
1.6
10.5
381
2795
JN4AD
NOMESCO Finland
Body CT examination
2.1
10.5
102
510
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
10.4
10
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
10.4
278
1894
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.8
10.4
51
186
WX704
NOMESCO Finland
Intubation
2.2
10.4
89
423
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
10.3
105
533
SPAT1255
SPAT
Intravenous administration of medicine
2.4
10.3
75
332
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
3.7
10.3
32
88
J05AB01
ATC
aciclovir; systemic
1.7
10.1
222
1438
A41.9
ICD-10 Finland
Sepsis, unspecified
3.0
10.1
45
156
SPAT1216
SPAT
Assessment of functional ability
1.8
10.0
151
878
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
9.9
124
678
N03AX23
ATC
brivaracetam; systemic
16.9
9.9
15
9
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.2
9.8
89
433
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
9.8
199
1262
A69.2
ICD-10 Finland
Lyme disease
2.4
9.7
66
284
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
9.7
154
910
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.7
9.6
52
200
G40
ICD-10 Finland
Epilepsy
5.1
9.6
20
40
N02AA05
ATC
oxycodone; systemic
1.8
9.6
165
998
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.8
9.6
21
44
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
30.3
9.4
12
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
9.4
225
1488
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
9.4
9
*
G05.1*J11.8
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis in suspected influenza
+∞
9.4
9
*
SPAT1167
SPAT
Insertion of urinary catheter
3.2
9.4
36
114
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
9.4
139
803
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.1
9.3
93
469
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.7
9.3
49
186
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.4
9.2
65
285
G61.0
ICD-10 Finland
Guillain-Barré syndrome
11.6
9.1
16
14
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
9.0
77
365
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
8.7
111
610
N06AX21
ATC
duloxetine; oral
1.9
8.6
120
679
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.8
8.6
41
148
N06AA09
ATC
amitriptyline; systemic
2.0
8.6
91
470
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.4
8.5
30
90
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
27.8
8.5
11
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.7
8.5
26
71
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
8.5
129
751
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.2
8.5
68
315
H02AB04
ATC
methylprednisolone; systemic
1.8
8.4
147
891
A84.8
ICD-10 Finland
Other tick-borne viral encephalitis
90.8
8.4
9
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
8.4
97
516
M35.1
ICD-10 Finland
Other overlap syndromes
12.9
8.4
14
11
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.2
8.3
73
350
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
8.3
58
253
WX872
NOMESCO Finland
Intensive care
2.4
8.3
57
247
N05BA04
ATC
oxazepam; oral
1.6
8.2
254
1779
B01AB05
ATC
enoxaparin; parenteral
1.5
8.2
290
2092
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
8.2
113
637
R51
ICD-10 Finland
Headache
2.3
8.1
64
294
L01BA01
ATC
methotrexate; systemic
2.8
8.1
40
147
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.8
8.1
24
64
G41.2
ICD-10 Finland
Complex partial status epilepticus
33.6
8.1
10
*
WW200
NOMESCO Finland
Immunization
3.1
8.1
33
109
NF1AA
NOMESCO Finland
Hip X-ray examination
2.0
8.0
82
417
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.6
8.0
45
177
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
8.0
63
290
OAB93, ,
SPAT
2.2
7.9
69
330
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
4.7
7.9
18
39
ZXA00
NOMESCO Finland
Right side
1.6
7.9
246
1727
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.9
7.9
93
499
J01FF01
ATC
clindamycin; systemic
1.5
7.8
259
1840
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.1
7.8
21
52
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.1
7.8
31
101
A04
ICPC
Weakness/tiredness general
1.7
7.8
143
880
A02BC01
ATC
omeprazole; systemic
1.5
7.7
257
1827
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
7.7
721
6253
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
6.0
7.7
20
34
H53.1
ICD-10 Finland
Subjective visual disturbances
2.1
7.7
71
348
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
7.7
107
606
XCK00
NOMESCO Finland
Perimetry
2.2
7.6
61
282
N02AX02
ATC
tramadol; systemic, rectal
1.5
7.6
403
3144
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
7.6
88
468
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
18.5
7.6
11
6
N06BA07
ATC
modafinil; oral
11.9
7.6
13
11
L04AX07
ATC
dimethyl fumarate; oral
8.9
7.6
15
17
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
8.9
7.6
15
17
UKC02
NOMESCO Finland
Cystoscopy
1.7
7.5
142
879
Z3229
NOMESCO Finland
Other healthcare associate professional
2.0
7.5
82
428
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
4.4
7.4
18
41
L03AB07
ATC
interferon beta-1a; parenteral
7.7
7.4
16
21
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
13.5
7.4
12
9
N03AX25
ATC
cenobamate; oral
+∞
7.3
7
*
32099
ICD-8 Finland
Meningitis, With no organism specified as cause
+∞
7.3
7
*
N02BE01
ATC
paracetamol; systemic, rectal
1.6
7.3
902
8229
H53.4
ICD-10 Finland
Visual field defects
3.4
7.3
25
74
WX882
NOMESCO Finland
High dependency care
2.8
7.3
35
127
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.8
7.2
19
33
R5110, ,
SPAT
2.2
7.2
61
289
M32
ICD-10 Finland
Systemic lupus erythematosus
30.2
7.2
9
*
K59.09
ICD-10 Finland
Constipation, unspecified
2.1
7.1
65
317
G40.10
ICD-10 Finland
Simple partial seizures
8.0
7.1
15
19
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.1
180
1201
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
7.1
64
311
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.5
7.1
42
170
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.0
7.0
29
97
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.0
521
4307
B34.9
ICD-10 Finland
Viral infection, unspecified
2.7
7.0
36
136
R60.0
ICD-10 Finland
Localized oedema
1.8
6.9
110
648
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.7
6.9
37
142
L04AA01
ATC
[U] ciclosporin
5.5
6.9
19
35
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
5.5
6.9
19
35
H46
ICD-10 Finland
Optic neuritis
5.5
6.9
19
35
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
6.9
289
2148
N05AH03
ATC
olanzapine; systemic
2.0
6.9
71
363
R41.3
ICD-10 Finland
Other amnesia
3.0
6.9
30
103
N18
ICPC
Paralysis/weakness
3.5
6.9
23
67
N30.0
ICD-10 Finland
Acute cystitis
1.6
6.8
151
975
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.3
6.8
51
230
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
40.3
6.8
8
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
16.8
6.7
10
6
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
6.7
61
298
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
6.7
192
1319
SPAT1234
SPAT
Support of social functional capacity
2.3
6.7
51
232
5CM18, ,
NOMESCO Finland
7.9
6.6
14
18
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.2
6.6
55
259
L04AD01
ATC
ciclosporin; systemic
3.2
6.6
25
79
TKC22
NOMESCO Finland
Catheterisation instruction
3.2
6.6
25
79
U07
ICPC
Urine symptom/complaint other
2.0
6.6
68
348
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
6.6
260
1909
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
10.1
6.5
12
12
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
6.5
383
3026
N88
ICPC
Epilepsy
6.9
6.5
15
22
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.0
6.5
71
371
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.5
6.5
39
159
U08
ICPC
Urinary retention
3.7
6.5
20
55
T78.4
ICD-10 Finland
Allergy, unspecified
2.3
6.5
47
209
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.4
6.5
43
184
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.0
6.5
72
379
A89
ICD-10 Finland
Unspecified viral infection of central nervous system
70.3
6.4
7
*
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
70.3
6.4
7
*
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
70.3
6.4
7
*
B02.8
ICD-10 Finland
Zoster with other complications
7.5
6.4
14
19
N86
ICPC
Multiple sclerosis
7.5
6.4
14
19
Z71.8
ICD-10 Finland
Other specified counselling
1.4
6.4
295
2230
N05CD07
ATC
temazepam; oral
1.7
6.4
106
633
XW000
NOMESCO Finland
Bone marrow biopsy
2.4
6.4
42
179
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
6.4
179
1223
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
6.3
65
332
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.4
6.3
42
180
XKC03
NOMESCO Finland
Water cystometry
2.7
6.3
32
120
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
6.3
87
492
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
18.1
6.3
9
5
GBB03
NOMESCO Finland
Percutaneous tracheostomy
+∞
6.3
6
*
B01.1
ICD-10 Finland
Varicella encephalitis
+∞
6.3
6
*
G06.0
ICD-10 Finland
Intracranial abscess and granuloma
+∞
6.3
6
*
3238X
ICD-9 Finland
Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS, ENCEPHALOMYELITIS) ALIA DEF]
+∞
6.3
6
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.6
6.3
34
132
A12AA12
ATC
[U] calcium acetate
26.8
6.2
8
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.1
6.2
58
286
WVA20
NOMESCO Finland
Medicine administration
2.7
6.2
31
115
N05CD08
ATC
midazolam; nasal, systemic
2.8
6.2
29
104
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.1
6.2
59
294
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
5.8
6.2
16
28
R55
ICD-10 Finland
Syncope and collapse
1.7
6.2
102
609
PA6AD
NOMESCO Finland
CT of neck arteries
2.8
6.2
30
110
K90
ICPC
Stroke/cerebrovascular accident
2.7
6.1
31
116
G93.4
ICD-10 Finland
Encephalopathy, unspecified
12.6
6.1
10
8
N03AX22
ATC
perampanel; oral
12.6
6.1
10
8
XLA10, ,
NOMESCO Finland
2.3
6.1
42
183
R06AE07
ATC
cetirizine; oral
1.4
6.1
419
3394
G83.4
ICD-10 Finland
Cauda equina syndrome
10.1
6.0
11
11
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.0
6.0
26
89
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.8
6.0
28
100
R60.9
ICD-10 Finland
Oedema, unspecified
2.2
6.0
50
236

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
310
183
23.40
307.65
1.7
1.4
92.94
8.53
e6/l
1.49
231
143
357
179
29.36
307.65
1.6
1.2
3.58
3.79
mmol/l
1.52
342
168
316
166
26.55
307.65
1.7
1.5
—
—
—
0
0
217
75
36.00
307.65
1.6
1.6
—
—
—
0
0
311
183
23.51
307.65
1.8
1.5
723.91
769.30
e6/l
0.02
239
148
230
71
40.94
307.65
1.4
1.9
—
—
—
0
0
361
202
26.40
307.65
1.7
1.3
695.95
459.55
mg/l
8.43
354
190
196
90
26.41
272.13
1.8
1.7
—
—
—
0
0
147
67
25.26
203.41
1.4
1.1
57.18
40.02
mg/l
1.64
131
53
141
63
25.61
196.50
1.2
1.1
334.93
233.11
mg/l
3.12
131
56
127
58
24.70
175.12
2.0
1.5
—
—
—
0
0
309
589
6.96
164.50
2.7
2.3
27.58
17.97
au/ml
0.37
12
47
288
526
7.11
159.54
1.5
1.3
69.36
39.20
au/ml
0.99
13
35
280
659
5.39
116.02
3.4
2.6
9.90
10.58
g/l
1.64
258
605
101
105
10.51
88.20
1.2
1.1
—
—
—
0
0
69
41
17.91
83.90
1.2
1.2
—
—
—
0
0
79
76
11.14
72.62
3.1
2.1
1.28
1.11
e9/l
0.76
73
67
479
2199
3.13
71.43
5.4
4.2
—
—
—
0
0
66
50
14.00
70.43
3.2
2.2
0.24
0.18
e9/l
1.07
60
42
67
53
13.42
69.71
3.1
2.1
516.12
491.16
e6/l
0.10
60
43
497
2449
2.91
63.44
3.0
2.1
226.19
261.52
u/l
0.23
484
2310
320
1258
3.20
60.87
2.7
2.2
28.88
29.67
s
2.28
314
1221
50
37
14.12
53.92
1.5
1.0
1585.74
1549.03
miu/ml
0.06
50
37
611
3596
2.62
51.70
9.2
6.5
1.20
1.21
mmol/l
2.86
563
3293
592
3458
2.58
50.49
6.0
5.0
34.85
35.89
g/l
3.86
560
3227
118
262
4.94
50.44
4.7
1.5
0.20
0.23
g/l
2.76
110
252
40
22
18.85
50.13
2.7
2.0
184.17
271.11
e6/l
—
24
9
682
4298
2.61
48.97
9.6
5.9
0.60
0.57
e9/l
1.74
602
3744
119
273
4.78
48.87
4.8
1.5
1.09
1.18
g/l
2.70
111
261
682
4306
2.60
48.65
9.6
5.9
0.04
0.04
e9/l
0.01
601
3751
641
3932
2.56
48.60
9.8
6.1
0.64
0.67
%
0.52
615
3684
644
4005
2.52
46.69
10.0
7.1
1.21
1.21
mmol/l
0.87
551
3426
649
4061
2.51
46.26
9.9
6.1
2.46
2.84
%
4.49
624
3815
689
4442
2.53
45.86
9.7
6.0
1.86
2.00
e9/l
0.71
618
3951
650
4082
2.50
45.78
10.3
6.4
8.75
8.49
%
1.14
626
3841
97
198
5.29
45.61
3.0
3.5
27.69
34.49
umol/l
3.03
85
181
690
4462
2.53
45.45
10.5
6.3
0.17
0.19
e9/l
1.88
613
3935
733
4884
2.57
45.11
7.7
5.0
6.65
6.65
mmol/l
0.04
704
4541
39
26
15.53
44.42
1.3
1.2
17.07
17.00
%
—
15
5
423
2227
2.48
43.38
4.3
3.0
—
—
—
0
0
657
4211
2.44
43.24
10.1
6.1
26.49
28.29
%
4.02
632
3970
649
4155
2.42
42.55
9.6
5.9
58.47
56.96
%
2.44
626
3922
406
2117
2.47
42.31
5.1
4.0
90.42
91.65
%
0.47
397
2061
425
2274
2.44
41.71
4.5
3.1
0.27
0.43
e6/l
1.77
335
1720
162
528
3.44
40.68
2.3
1.7
1.13
1.43
g/l
1.15
144
489
630
4064
2.33
39.39
10.8
6.5
—
—
—
0
0
725
4987
2.39
38.70
13.4
9.1
4.27
4.06
e9/l
1.51
644
4371
446
2501
2.34
38.67
4.5
3.2
28.25
84.09
e6/l
1.30
352
1917
499
2958
2.28
37.67
5.3
3.7
41.41
96.70
e6/l
2.19
373
2062
167
594
3.14
36.15
2.3
2.9
66.07
66.77
g/l
0.43
151
548
423
2372
2.29
36.12
5.2
3.9
7.41
7.40
ph
1.20
65
451
580
3706
2.23
35.86
15.0
13.6
1.21
1.23
inr
0.19
148
1143
286
1363
2.50
35.24
3.9
2.8
0.93
1.03
e6/l
0.31
162
763
353
1873
2.32
33.97
1.7
1.9
—
—
—
0
0
239
1077
2.57
32.92
7.9
6.1
1.03
1.05
mmol/l
0.48
221
998
792
5875
2.32
32.24
6.9
4.1
—
—
—
0
0
272
1320
2.42
31.83
4.5
3.8
0.81
0.82
mmol/l
0.44
247
1251
141
491
3.15
31.46
2.0
2.5
—
—
—
0
0
48
74
6.74
30.01
1.3
1.3
6.90
7.66
g/l
0.36
36
52
754
5578
2.18
29.42
6.5
4.2
388.00
1416.15
e6/l
—
7
84
263
1297
2.36
29.42
4.1
2.9
2.97
2.51
e6/l
0.22
139
699
35
8
45.11
28.82
1.4
4.0
—
—
—
0
0
47
74
6.60
28.80
1.3
1.3
0.34
0.40
g/l
0.36
35
51
47
74
6.60
28.80
1.3
1.3
3.17
2.77
g/l
0.36
35
51
319
1721
2.21
28.70
3.2
2.5
4.61
6.29
e6/l
1.89
292
1559
47
76
6.42
28.07
1.3
1.3
—
—
—
0
0
308
1651
2.21
28.07
4.0
2.9
542.98
550.76
mosm/kgh2o
0.25
263
1429
90
258
3.72
27.19
2.0
2.6
10.48
10.35
g/l
0.06
74
235
183
792
2.58
27.02
2.5
2.1
355.08
370.69
nmol/l
0.55
172
734
618
4340
2.00
26.52
7.1
6.3
10.51
11.94
umol/l
2.99
590
4117
827
6490
2.19
25.64
10.4
7.4
77.16
78.31
u/l
0.38
793
6125
488
3185
1.97
25.61
2.3
1.9
91.84
94.90
pmol/l
0.70
267
1669
365
2151
2.06
25.58
9.9
6.7
—
—
—
0
0
58
129
4.70
24.54
1.3
1.8
0.43
0.92
g/l
2.36
45
99
82
240
3.62
23.99
1.9
2.2
11.28
11.05
mg/l
0.08
73
221
77
217
3.75
23.82
1.8
2.7
37.10
38.22
g/l
0.59
61
195
30
35
8.79
23.73
1.4
1.4
—
—
—
0
0
279
1524
2.12
23.69
3.6
3.7
95.59
396.92
ng/l
3.71
209
1132
160
701
2.51
22.82
7.8
8.4
8.31
9.17
mmol/l
0.84
152
669
60
148
4.23
22.28
1.5
1.2
3.24
5.65
u/ml
0.70
38
60
157
693
2.48
22.00
11.3
9.2
—
—
—
0
0
36
57
6.50
21.92
3.4
2.6
43.19
42.47
%
0.06
22
28
395
2499
1.92
21.85
4.0
2.9
—
—
—
0
0
96
335
3.05
21.15
2.8
2.3
22.30
21.29
s
0.41
89
304
28
10
28.70
21.01
1.1
1.0
—
—
—
0
0
226
1194
2.13
20.63
1.7
1.3
466.29
490.44
titre
0.08
70
249
256
1426
2.04
20.24
1.8
1.7
999.82
1176.45
nmol/l
2.77
200
1076
159
736
2.36
19.97
10.1
7.9
1.42
1.39
mmol/l
0.16
149
718
540
3850
1.81
19.84
13.1
9.2
0.00
0.00
e9/l
0.54
439
3159
211
1101
2.14
19.82
1.7
1.6
—
—
—
0
0
164
776
2.31
19.56
4.6
4.1
1.67
1.82
mmol/l
0.20
140
636
53
132
4.17
19.44
4.1
5.8
325.59
380.43
umol/l
2.25
46
114
24
7
35.02
18.95
1.0
1.0
—
—
—
0
0
781
6281
1.89
18.78
6.0
4.0
13.30
11.32
mm/h
3.06
738
5823
309
1898
1.88
18.08
4.6
3.4
—
—
—
0
0
176
888
2.17
17.89
11.7
9.0
1.41
1.08
mmol/l
0.45
138
705
29
46
6.45
17.62
1.2
1.3
122.72
152.63
nmol/l
2.09
29
46
176
894
2.16
17.57
11.7
8.9
5.05
5.09
kpa
0.21
163
858
176
895
2.16
17.51
11.7
8.9
12.02
12.36
kpa
0.39
163
862
486
3450
1.75
17.35
2.7
2.3
74.67
75.63
nmol/l
0.30
443
3124
141
664
2.29
16.91
3.7
3.6
4.87
4.58
kpa
0.72
135
644
476
3383
1.73
16.75
4.7
3.3
6.09
5.87
ph
0.80
34
290
415
2846
1.75
16.53
4.3
3.3
43.47
32.23
u/l
0.64
387
2719
75
262
3.00
16.47
1.2
1.1
—
—
—
0
0
39
89
4.51
16.00
1.2
1.1
—
—
—
0
0
186
1002
2.04
15.79
2.2
1.7
—
—
—
0
0
88
345
2.69
15.61
2.5
2.1
1.72
1.46
g/l
1.57
74
301
399
2746
1.72
15.44
3.7
3.3
2.34
2.35
mmol/l
1.52
352
2447
287
1805
1.80
15.17
2.0
1.4
2.15
2.39
g/l
1.81
205
1120
60
195
3.20
14.90
1.2
1.5
—
—
—
0
0
324
2124
1.75
14.80
2.4
2.2
3.09
2.95
mg/l
0.36
274
1806
303
1964
1.76
14.33
2.0
1.8
1.00
1.15
mg/l
0.40
236
1468
974
8712
2.26
13.95
25.2
13.4
22.78
23.01
mg/l
0.08
851
6837
554
4231
1.64
13.94
5.3
3.5
0.00
0.01
estimate
0.80
102
778
723
5907
1.68
13.93
4.3
3.2
51.59
46.67
u/l
1.00
683
5567
548
4177
1.64
13.88
7.5
4.8
0.00
0.00
estimate
0.50
104
809
142
725
2.10
13.84
1.6
1.4
—
—
—
0
0
548
4183
1.63
13.75
5.3
3.5
0.02
0.00
estimate
0.45
108
854
430
3092
1.65
13.69
4.5
3.5
41.32
43.39
ng/l
0.07
305
2042
151
797
2.04
13.45
12.7
9.5
95.64
95.79
%
0.08
146
768
45
131
3.54
13.29
1.3
1.4
67.22
65.73
mmol/l
0.07
37
111
163
888
1.98
13.28
2.8
2.9
1.77
1.79
%
0.06
141
808
24
42
5.82
13.24
1.0
1.0
395.58
241.48
ng/l
0.91
19
23
145
767
2.03
12.82
2.2
2.4
38.74
36.13
u/l
0.09
130
646
180
1026
1.91
12.82
1.4
1.7
—
—
—
0
0
23
42
5.57
12.15
1.0
1.0
680.94
580.54
ng/l
0.40
17
24
38
106
3.68
11.96
1.2
1.3
—
—
—
0
0
969
8753
2.09
11.85
27.4
15.2
139.14
139.64
mmol/l
7.35
958
8529
74
306
2.52
11.80
2.4
2.2
0.72
2.31
ug/l
0.96
67
272
53
184
2.98
11.80
1.3
1.5
90.62
101.56
u/ml
—
8
37
239
1527
1.73
11.58
1.7
1.7
—
—
—
0
0
110
550
2.11
11.28
1.5
1.3
121.32
232.73
u/ml
1.47
102
505
365
2616
1.60
11.25
2.9
2.5
57.70
59.70
u/l
0.31
344
2446
195
1187
1.79
11.15
2.5
2.1
—
—
—
0
0
44
143
3.17
10.96
1.1
1.0
—
—
—
0
0
90
420
2.25
10.96
13.9
11.1
24.37
24.45
mmol/l
0.07
83
411
967
8781
2.01
10.84
27.5
15.3
3.95
3.96
mmol/l
1.06
952
8544
38
114
3.42
10.76
2.4
2.5
—
—
—
0
0
275
1863
1.64
10.56
1.7
1.5
18.60
20.59
nmol/l
2.06
255
1599
45
152
3.05
10.52
1.1
1.1
—
—
—
0
0
887
7867
1.73
10.43
5.4
4.6
1.81
2.03
mu/l
0.83
829
7262
23
30
7.81
10.41
2.5
1.7
—
—
—
0
0
366
2663
1.57
10.40
2.7
2.4
—
—
—
0
0
33
94
3.59
10.10
1.4
1.5
281.29
282.37
mosm/kgh2o
0.07
24
65
57
225
2.62
10.01
1.9
1.2
18.08
2.60
u/ml
0.80
11
24
54
208
2.68
9.95
1.2
1.4
325.97
241.32
u/ml
0.67
34
129
57
226
2.61
9.92
1.8
1.2
8.58
10.22
u/ml
0.09
13
35
120
649
1.96
9.90
2.8
3.0
67.41
71.78
e9/l
0.67
88
501
45
160
2.89
9.64
3.0
3.8
—
—
—
0
0
138
792
1.85
9.51
2.9
2.4
0.23
0.21
g/l
0.99
123
746
111
607
1.92
8.86
4.3
4.1
80.39
81.88
ng/l
0.07
94
540
117
653
1.89
8.78
4.6
4.4
0.61
0.59
%
0.06
62
227
96
502
2.00
8.72
8.1
6.2
—
—
—
0
0
53
218
2.51
8.59
3.3
3.7
34.02
79.78
mg/l
0.89
46
173
53
218
2.51
8.59
3.3
3.7
91.57
32.45
mg/l
0.57
47
173
216
1444
1.62
8.57
3.4
2.9
2.45
2.44
mmol/l
0.24
183
1277
102
549
1.95
8.53
4.5
4.4
7.39
7.41
ph
—
10
65
754
6543
1.51
8.52
4.6
3.9
14.88
14.69
pmol/l
1.15
707
5990
83
416
2.08
8.46
16.0
12.6
—
—
—
0
0
124
714
1.83
8.44
5.0
4.6
0.90
0.95
%
0.09
68
262
47
185
2.61
8.34
1.9
1.2
34.98
40.44
u/ml
—
6
13
26
72
3.68
8.32
1.7
1.2
—
—
—
0
0
102
556
1.92
8.22
4.6
4.4
5.26
5.11
kpa
1.05
97
537
184
1193
1.65
8.22
3.1
2.4
2.32
2.35
g/l
0.26
173
1103
48
193
2.56
8.16
1.3
1.2
—
—
—
0
0
173
1112
1.66
7.98
3.2
2.4
19.11
23.19
%
4.27
144
956
117
675
1.82
7.91
5.1
4.7
0.16
0.10
%
0.52
61
222
41
155
2.71
7.88
1.2
1.7
—
—
—
0
0
51
216
2.43
7.79
3.4
3.6
1.37
1.98
ratio
—
6
21
490
3958
1.44
7.72
3.0
2.6
—
—
—
0
0
193
1288
1.61
7.65
3.1
2.4
11.89
13.28
umol/l
1.83
180
1196
117
683
1.80
7.61
1.4
1.4
—
—
—
0
0
25
72
3.53
7.57
1.4
1.1
—
—
—
0
0
281
2047
1.50
7.52
2.6
2.3
—
—
—
0
0
30
98
3.12
7.48
3.6
3.9
—
—
—
0
0
161
1035
1.65
7.40
1.5
1.4
—
—
—
0
0
17
25
6.89
7.31
1.5
1.4
—
—
—
0
0
78
404
2.00
7.29
4.6
4.6
—
—
—
0
0
38
144
2.70
7.29
1.3
1.4
—
—
—
0
0
288
2121
1.49
7.27
3.3
2.7
1617.22
5800.06
umol/l
1.96
254
1865
475
3844
1.42
7.27
3.3
2.8
139.72
117.85
ug/l
0.77
434
3567
110
640
1.80
7.23
4.9
4.8
0.08
0.58
%
0.54
51
188
68
338
2.08
7.11
1.3
1.3
—
—
—
0
0
62
300
2.13
6.96
4.2
3.6
0.19
0.35
g/l
1.66
36
135
15
20
7.59
6.91
1.5
1.3
—
—
—
0
0
295
2207
1.46
6.82
3.0
3.2
1076.81
1324.39
ng/l
0.96
245
1866
36
138
2.66
6.77
1.4
1.1
37198.14
72.81
iu/ml
—
7
32
39
157
2.54
6.66
2.1
1.9
5.06
4.85
mmol/24h
0.15
30
138
110
656
1.75
6.66
4.2
3.2
—
—
—
0
0
244
3258
0.68
6.64
2.7
2.6
—
—
—
0
0
47
207
2.33
6.62
5.5
3.9
7.42
7.42
ph
0.03
41
182
42
177
2.43
6.52
4.8
4.4
—
—
—
0
0
41
172
2.44
6.43
5.8
4.1
2.82
2.31
mmol/l
0.62
29
112
13
17
7.73
6.13
1.4
1.1
16.29
17.79
umol/l
0.46
13
17
17
44
3.91
6.00
1.5
1.8
—
—
—
0
0
103
622
1.73
5.97
2.3
3.0
184.58
207.85
ng/l
0.18
94
562
50
238
2.15
5.88
3.9
3.2
—
—
—
0
0
21
65
3.28
5.74
1.1
1.1
0.09
1.27
nmol/l
—
5
12
145
973
1.57
5.56
3.2
3.1
7.78
8.57
umol/l
0.21
118
840
969
9118
1.64
5.48
20.7
12.4
—
—
—
0
0
976
9207
1.65
5.38
16.2
9.9
27.93
26.86
u/l
1.02
950
8918
227
1704
1.42
4.98
1.6
1.7
33981012.07
29453441.44
pmol/l
0.05
206
1426
25
94
2.70
4.94
1.8
1.6
—
—
—
0
0
25
94
2.70
4.94
1.3
1.2
—
—
—
0
0
17
51
3.37
4.90
1.1
1.0
—
—
—
0
0
654
5802
1.32
4.73
3.9
3.6
—
—
—
0
0
16
48
3.37
4.61
1.1
1.0
—
—
—
0
0
11
18
6.16
4.61
3.4
2.0
15.35
16.46
umol/l
0.11
11
18
40
194
2.10
4.55
3.9
2.5
—
—
—
0
0
401
3340
1.32
4.49
2.0
2.1
—
—
—
0
0
55
302
1.87
4.42
6.3
4.9
—
—
—
0
0
91
578
1.63
4.40
2.9
2.6
5.45
5.64
e9/l
0.05
74
487
824
7615
1.35
4.17
29.2
16.0
14.81
14.62
%
0.44
814
7488
100
659
1.57
4.16
2.3
2.4
4.44
7.73
ug/l
2.68
83
582
11
21
5.28
4.15
2.0
1.4
—
—
—
0
0
113
768
1.53
4.10
5.8
4.3
—
—
—
0
0
96
629
1.58
4.10
1.3
1.2
188.91
156.60
iu/ml
0.26
34
256
90
588
1.58
3.90
1.3
1.4
—
—
—
0
0
191
1449
1.39
3.90
1.3
1.3
18.44
30.03
iu/ml
1.83
53
463
278
2243
1.32
3.79
3.9
3.3
965.46
309.72
mg/l
0.82
194
1469
6
5
12.06
3.76
1.2
1.0
—
—
—
0
0
290
2372
1.30
3.56
4.9
3.9
11.89
9.93
mg/mmol
0.31
197
1531
306
2521
1.30
3.56
4.4
3.2
7.62
7.83
mmol/l
0.30
257
2160
34
174
1.99
3.42
5.7
3.3
—
—
—
0
0
12
32
3.78
3.39
3.1
3.2
28.57
35.32
umol/l
—
7
25
80
527
1.56
3.37
3.2
3.4
4.32
4.57
pmol/l
1.23
66
466
8
14
5.75
3.34
1.5
1.7
—
—
—
0
0
26
121
2.18
3.34
3.3
3.2
—
—
—
0
0
33
170
1.97
3.27
4.5
3.6
3.92
4.20
e9/l
0.36
33
170
100
697
1.48
3.25
1.2
1.2
—
—
—
0
0
22
97
2.29
3.21
1.2
1.4
5493.07
376.08
pmol/l
0.47
17
87
12
34
3.56
3.20
1.3
1.6
—
—
—
0
0
19
79
2.43
3.15
3.9
3.1
—
—
—
0
0
11
30
3.69
3.09
1.0
1.1
—
—
—
0
0
11
30
3.69
3.09
1.1
1.1
—
—
—
0
0
11
31
3.57
2.99
1.0
1.0
—
—
—
0
0
33
176
1.90
2.98
5.0
3.9
57.21
56.85
%
0.06
33
176
269
2227
1.28
2.95
5.9
3.7
0.00
0.01
estimate
1.08
99
788
76
511
1.52
2.95
4.4
2.7
—
—
—
0
0
91
636
1.47
2.94
5.9
3.7
1.22
1.23
mmol/l
1.27
81
558
17
70
2.45
2.89
1.1
1.1
—
—
—
0
0
66
972
0.66
2.79
1.3
1.3
—
—
—
0
0
59
380
1.58
2.78
2.0
2.4
1960.76
3448.01
u/l
0.54
17
168
228
1864
1.28
2.75
6.0
3.7
1.02
1.02
kg/l
0.47
39
255
51
318
1.63
2.74
1.3
1.3
245.00
255.62
miu/ml
0.05
20
151
15
60
2.52
2.71
4.4
3.4
—
—
—
0
0
9
24
3.77
2.67
1.1
1.1
—
—
—
0
0
34
192
1.80
2.61
2.4
2.4
—
—
—
0
0
806
7587
1.25
2.56
30.5
16.9
332.91
333.00
g/l
0.10
798
7535
816
7694
1.25
2.54
6.3
5.4
40.18
39.51
mmol/mol
0.93
763
7186
92
664
1.42
2.54
2.0
2.2
12.97
12.91
nmol/l
0.02
83
606
7
16
4.40
2.47
1.0
1.4
—
—
—
0
0
13
51
2.57
2.45
1.1
1.1
1.03
1.07
ratio
—
7
22
31
174
1.80
2.44
3.0
2.2
16.87
16.41
%
0.20
14
89
22
110
2.02
2.42
1.9
1.8
—
—
—
0
0
44
274
1.63
2.41
1.3
1.2
—
—
—
0
0
10
33
3.05
2.36
3.0
2.6
38.97
92.98
ug/l
—
10
33
9
29
3.12
2.23
2.8
3.0
—
—
—
0
0
69
485
1.45
2.22
1.4
1.2
—
—
—
0
0
9
30
3.02
2.15
2.4
3.1
—
—
—
0
0
9
30
3.02
2.15
7.0
4.2
—
—
—
0
0
34
206
1.67
2.09
1.6
1.2
—
—
—
0
0
10
37
2.72
2.07
2.9
3.1
42351.60
39346.08
ug/l
—
10
37
10
37
2.72
2.07
1.9
5.4
72.40
66.38
mg/l
—
10
26
241
2049
1.23
2.05
1.3
1.3
2.76
1.58
u/ml
0.25
45
561
50
335
1.52
2.05
1.1
1.2
—
—
—
0
0
57
395
1.47
1.99
2.8
2.4
—
—
—
0
0
9
33
2.74
1.93
1.0
1.1
—
—
—
0
0
50
340
1.49
1.93
2.2
1.8
—
—
—
0
0
40
601
0.65
1.92
1.3
1.4
—
—
—
0
0
1002
9770
1.38
1.90
34.8
19.5
7.06
6.74
e9/l
3.75
980
9517
1001
9760
1.37
1.89
35.4
19.7
39.67
40.37
%
3.85
939
9182
1001
9762
1.37
1.87
34.8
19.5
257.37
251.27
e9/l
1.95
984
9533
25
144
1.75
1.86
1.1
1.2
—
—
—
0
0
5
12
4.18
1.82
1.0
1.2
—
—
—
0
0
1001
9766
1.36
1.82
34.7
19.5
91.01
90.58
fl
1.86
988
9640
1001
9767
1.36
1.81
34.6
19.4
30.33
30.22
pg
1.06
987
9640
1001
9768
1.36
1.80
34.8
19.5
4.41
4.53
e12/l
10.50
977
9517
13
60
2.18
1.78
1.2
1.3
—
—
—
0
0
1001
9773
1.35
1.74
35.0
19.6
132.74
136.11
g/l
10.34
987
9641
19
103
1.86
1.72
1.0
1.2
—
—
—
0
0
23
133
1.75
1.71
2.8
1.6
—
—
—
0
0
17
89
1.92
1.70
1.4
1.4
—
—
—
0
0
49
342
1.45
1.69
3.6
1.9
—
—
—
0
0
34
220
1.56
1.66
1.9
1.9
8.66
5.56
iu/l
0.65
11
75
49
344
1.44
1.65
1.1
1.1
—
0.92
—
0
5
29
181
1.62
1.64
2.2
2.0
127.94
129.95
g/l
0.14
17
135
11
49
2.26
1.64
1.4
1.3
—
—
—
0
0
10
42
2.39
1.62
2.9
2.3
—
—
—
0
0
5
14
3.58
1.61
1.2
1.0
—
—
—
0
0
14
70
2.01
1.59
1.0
1.2
1.32
1.94
u/ml
—
7
37
6
20
3.01
1.58
1.2
1.5
—
—
—
0
0
5
15
3.34
1.52
2.4
1.3
—
—
—
0
0
25
155
1.63
1.47
3.1
2.6
—
—
—
0
0
16
87
1.85
1.46
1.7
1.9
17.35
20.67
nmol/l
1.22
16
82
5
16
3.13
1.44
1.4
1.6
—
—
—
0
0
9
41
2.20
1.37
1.2
1.1
416.22
483.08
u/l
—
9
36
9
41
2.20
1.37
1.4
1.2
—
—
—
0
0
10
48
2.09
1.28
1.4
1.2
—
—
—
0
0
133
1123
1.21
1.24
2.5
2.5
219.49
126.08
ug/g
0.84
109
906
8
36
2.23
1.24
1.0
1.3
—
—
—
0
0
0
34
0.00
1.16
0.0
3.0
—
—
—
0
0
0
34
0.00
1.16
0.0
6.0
—
—
—
0
0
262
2362
1.14
1.11
5.2
3.2
—
—
—
0
0
51
390
1.32
1.10
6.4
3.7
—
—
—
0
0
89
731
1.24
1.10
6.1
3.6
—
—
—
0
0
5
21
2.39
1.09
3.0
1.4
—
—
—
0
0
13
74
1.77
1.07
1.2
1.2
—
—
—
0
0
33
237
1.40
1.05
1.7
1.4
257.55
306.92
ug/g
0.50
19
135
130
1118
1.19
1.02
1.2
1.2
—
—
—
0
0
256
2319
1.14
1.01
4.3
3.7
—
—
—
0
0
18
115
1.57
1.00
1.8
1.4
—
—
—
0
0
38
284
1.35
0.98
1.6
1.4
10.39
9.56
u/l
0.13
32
229
157
1380
1.16
0.96
1.3
1.3
4.99
10.46
u/ml
1.24
52
548
52
410
1.28
0.93
3.6
2.1
—
—
—
0
0
20
135
1.49
0.89
1.7
1.3
—
—
—
0
0
25
177
1.42
0.89
1.2
1.1
—
—
—
0
0
25
177
1.42
0.89
1.2
1.1
—
—
—
0
0
6
30
2.01
0.87
1.7
1.6
—
—
—
0
0
6
31
1.94
0.84
1.3
12.6
—
—
—
0
0
55
444
1.25
0.84
3.5
2.0
—
—
—
0
0
6
32
1.88
0.82
2.7
2.4
—
—
—
0
0
271
2498
1.11
0.81
3.7
4.7
2.45
2.55
ug/l
0.08
251
2243
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
11
67
1.65
0.75
2.1
5.3
10.79
11.33
%
0.14
11
67
25
184
1.37
0.74
1.8
1.7
9541.55
13011.13
e6/l
0.26
20
135
9
55
1.64
0.73
1.2
1.3
1.50
1.58
g/l
—
9
55
13
84
1.55
0.72
2.5
3.0
2.00
1.59
g/24h
—
5
50
7
40
1.75
0.71
1.7
1.1
140.53
205.50
iu/ml
—
7
40
15
102
1.48
0.67
2.1
2.7
—
—
—
0
0
27
205
1.33
0.67
2.0
1.2
—
—
—
0
0
54
449
1.21
0.66
3.5
2.0
—
—
—
0
0
50
413
1.22
0.65
1.3
1.4
32.55
24.73
iu/l
0.74
40
340
821
8388
0.91
0.64
4.4
4.1
1.42
1.45
mmol/l
1.55
757
7770
54
451
1.21
0.64
3.5
2.0
—
—
—
0
0
837
8189
1.10
0.64
4.7
4.2
6.00
5.90
mmol/l
1.03
772
7496
37
297
1.25
0.63
8.5
2.7
—
—
—
0
0
12
79
1.52
0.62
1.3
1.1
—
—
—
0
0
53
444
1.20
0.61
2.1
1.9
—
—
—
0
0
19
140
1.36
0.58
1.5
1.7
—
—
—
0
0
15
106
1.42
0.58
2.8
2.7
—
—
—
0
0
6
35
1.72
0.57
1.0
2.0
—
—
—
0
0
11
73
1.51
0.56
1.8
1.5
—
—
—
0
0
99
883
1.13
0.55
1.9
1.4
—
—
—
0
0
19
142
1.34
0.54
1.2
1.2
134.94
40.49
u/l
0.36
14
124
26
205
1.27
0.53
2.2
2.4
88.34
117.42
ug/min
0.24
16
126
11
75
1.47
0.50
1.5
2.4
—
—
—
0
0
45
380
1.19
0.50
1.1
1.1
—
—
—
0
0
6
41
1.47
0.50
1.2
1.4
—
—
—
0
0
10
67
1.50
0.49
1.4
1.6
1.06
1.02
g/l
—
10
67
102
920
1.12
0.48
1.3
1.3
—
—
—
0
0
7
47
1.49
0.47
1.0
1.3
8.50
6.12
ug/l
—
7
37
11
77
1.43
0.45
1.2
1.3
—
—
—
0
0
18
138
1.31
0.45
4.7
3.0
0.79
0.90
nmol/l
0.61
12
107
156
1447
1.09
0.44
2.8
2.9
0.76
0.77
ug/l
0.01
106
899
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
15
114
1.32
0.41
2.2
2.6
—
—
—
0
0
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
10
71
1.41
0.39
1.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.7
—
94.19
—
0
12
13
98
1.33
0.37
1.0
1.2
—
—
nmol/l
—
0
0
5
37
1.35
0.37
1.6
1.2
161.60
178.99
mmol/24h
—
5
37
15
116
1.30
0.37
2.2
2.7
104.07
105.24
mmol/l
0.21
15
116
15
116
1.30
0.37
2.2
2.7
4.21
4.09
mmol/l
0.58
15
116
9
70
1.29
0.36
1.6
1.2
—
—
—
0
0
17
212
0.80
0.36
1.1
1.1
—
—
—
0
0
832
8433
0.94
0.35
4.4
4.2
4.56
4.68
mmol/l
2.47
770
7863
262
2507
1.06
0.34
1.5
1.5
—
—
—
0
0
45
509
0.88
0.34
1.5
1.7
—
—
—
0
0
6
45
1.34
0.33
5.8
6.7
—
—
—
0
0
11
144
0.76
0.33
8.5
2.8
—
—
—
0
0
6
47
1.28
0.32
1.5
3.4
—
—
—
0
0
32
368
0.87
0.31
1.0
1.1
—
—
—
0
0
19
229
0.83
0.30
1.3
1.4
—
—
—
0
0
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
19
228
0.83
0.29
1.3
1.4
—
—
—
0
0
9
76
1.19
0.24
1.6
1.5
—
—
—
0
0
83
775
1.08
0.24
3.6
4.3
4.91
27.87
ug/l
1.39
62
635
12
147
0.81
0.23
1.2
1.2
—
—
—
0
0
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
16
135
1.19
0.21
1.9
2.9
7.55
7.26
umol/l
—
8
101
0
10
0.00
0.21
0.0
1.0
—
173.20
—
0
10
0
12
0.00
0.21
0.0
1.0
—
0.63
—
0
6
34
306
1.11
0.21
2.9
2.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
3.50
—
0
6
6
51
1.18
0.19
1.2
1.2
—
—
—
0
0
802
8092
0.96
0.18
4.1
3.8
1.38
1.29
mmol/l
1.85
737
7457
15
128
1.17
0.18
1.7
1.5
—
—
—
0
0
7
58
1.21
0.18
2.4
1.8
—
—
—
0
0
15
174
0.86
0.18
1.6
1.6
—
—
—
0
0
6
77
0.78
0.15
1.7
1.2
—
—
—
0
0
24
216
1.11
0.15
9.4
4.9
—
—
—
0
0
851
8568
0.97
0.15
4.9
4.6
2.66
2.79
mmol/l
3.65
782
7937
14
161
0.87
0.15
1.1
1.1
12.66
5.13
u/ml
—
8
91
29
316
0.92
0.14
1.8
1.7
—
—
—
0
0
10
84
1.19
0.14
1.0
1.1
—
—
—
0
0
100
1037
0.96
0.12
1.4
1.4
—
—
—
0
0
16
179
0.89
0.12
1.2
1.2
—
—
—
0
0
10
86
1.16
0.11
3.0
2.1
—
—
—
0
0
104
1070
0.97
0.09
1.1
1.2
—
—
—
0
0
14
155
0.90
0.09
1.1
1.1
1.54
1.36
u/ml
—
7
71
5
62
0.81
0.08
1.2
1.1
—
7.75
—
0
15
5
63
0.79
0.08
1.0
1.5
79.60
79.71
umol/l
—
5
63
7
68
1.03
0.08
1.1
1.3
6.54
6.92
mmol/l
—
7
63
25
266
0.94
0.07
10.2
10.0
—
—
—
0
0
28
265
1.06
0.07
1.1
1.1
1.68
6.82
u/ml
—
5
33
15
139
1.08
0.05
1.3
1.2
—
—
—
0
0
11
100
1.10
0.05
2.6
2.6
33.55
33.25
pg
0.09
11
100
17
180
0.94
0.04
1.1
1.1
0.61
3.53
u/ml
2.43
11
100
99
1005
0.98
0.03
1.9
1.8
—
—
—
0
0
56
550
1.02
0.02
1.2
1.2
—
—
—
0
0
218
2169
1.01
0.01
1.8
1.6
1.47
1.40
mmol/l
0.62
187
1852
14
144
0.97
0.00
1.0
1.0
4.07
1.93
u/ml
—
6
66
23
233
0.99
0.00
1.2
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
34.26
—
0
5
12
120
1.00
-0.00
1.1
1.1
2.49
4.33
u/ml
—
7
45
0
9
0.00
-0.00
0.0
4.0
—
14.29
—
0
9
0
7
0.00
-0.00
0.0
1.9
—
2.36
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
1142.67
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
12.87
—
0
7
6
59
1.02
-0.00
1.5
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
4.64
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint G6_ENCEPHOTH and mortality.

Females

Parameter HR [95% CI] p-value
G6_ENCEPHOTH 2.45 [2.02, 2.98] < 0.001
Birth year 0.991 [0.98, 1.0] 0.037

During the follow-up period (1.1.1998 — 31.12.2019), 661 out of 2876 females with G6_ENCEPHOTH died.

Males

Parameter HR [95% CI] p-value
G6_ENCEPHOTH 2.573 [2.12, 3.12] < 0.001
Birth year 0.987 [0.98, 1.0] 0.009

During the follow-up period (1.1.1998 — 31.12.2019), 676 out of 2598 males with G6_ENCEPHOTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_ENCEPHOTH.

N-year risk Females Males
1 0.27% 0.56%
5 1.504% 3.404%
10 3.471% 7.97%
15 6.499% 14.497%
20 10.676% 23.104%

Relationships between endpoints

↥

Index endpoint: G6_ENCEPHOTH – Other encephalitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data